Fully Automatic End-to-End Convolutional Neural Networks-Based Pancreatic Tumor Segmentation on CT Modality
Turkish Journal of Forecasting · 2022
DOI: 10.34110/forecasting.1190299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Forecasting, 2022. Verfasst von Ahmet Furkan BAYRAM und 3 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
The pancreas is one of the vital organs in the human body. Early diagnosis of a disease in the pancreas is critical. In this way, the effects of pancreas diseases, especially pancreatic cancer on the person are decreased. With this purpose, artificial intelligence-assisted pancreatic cancer segmentation was performed for early diagnosis in this paper. For this aim, several state-of-the-art segmentation networks, UNet, LinkNet, SegNet, SQ-Net, DABNet, EDANet, and ESNet were used in this study. In the comparative analysis, the best segmentation performance has been achieved by SQ-Net. SQ-Net has achieved a 0.917 dice score, 0.847 IoU score, 0.920 sensitivity, 1.000 specificity, 0.914 precision, and 0.999 accuracy. Considering these results, an artificial intelligence-based decision support system was created in the study.
Zitieren
APA
BAYRAM, A. F., GURKAN, C., BUDAK, A., & KARATAŞ, H. (2022). Fully Automatic End-to-End Convolutional Neural Networks-Based Pancreatic Tumor Segmentation on CT Modality. Turkish Journal of Forecasting. https://doi.org/10.34110/forecasting.1190299
Vancouver
BAYRAM AF, GURKAN C, BUDAK A, KARATAŞ H. Fully Automatic End-to-End Convolutional Neural Networks-Based Pancreatic Tumor Segmentation on CT Modality. Turkish Journal of Forecasting. 2022. doi:10.34110/forecasting.1190299
BibTeX
@article{BAYRAM2022,
author = {BAYRAM, Ahmet Furkan and GURKAN, Caglar and BUDAK, Abdulkadir and KARATAŞ, Hakan},
title = {Fully Automatic End-to-End Convolutional Neural Networks-Based Pancreatic Tumor Segmentation on CT Modality},
journal = {Turkish Journal of Forecasting},
year = {2022},
doi = {10.34110/forecasting.1190299}
}
EUVIMED